Amneal Pharmaceuticals (AMRX) Profit After Tax Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 32.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.86% |
| Mar 31, 2026 | 122.17% |
| Dec 31, 2025 | 136.05% |
| Sep 30, 2025 | 32.21% |
| Jun 30, 2025 | 27.92% |
| Mar 31, 2025 | 50.12% |
| Dec 31, 2024 | -46.06% |
| Sep 30, 2024 | 57.81% |
| Jun 30, 2024 | -42.89% |
| Mar 31, 2024 | -102.47% |
| Dec 31, 2023 | -141.98% |
| Sep 30, 2023 | 34.76% |
| Jun 30, 2023 | 47.97% |
| Mar 31, 2023 | -27.18% |
| Dec 31, 2022 | 27.20% |
| Sep 30, 2022 | 69.37% |
| Jun 30, 2022 | -142.18% |
| Mar 31, 2022 | 43.11% |
| Dec 31, 2021 | -0.21% |
| Sep 30, 2021 | 42.67% |